DLEU7 antibody (AA 51-100)
Quick Overview for DLEU7 antibody (AA 51-100) (ABIN7228232)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-100
-
Purpose
- DLEU7 Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of DLEU7
-
Purification
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen
-
Immunogen
- Synthesized peptide derived from part region of human DLEU7 protein at AA range: 51-100
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC-P (1:50-1:200), ELISA (1:10000-1:20000).
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol as stabilizer.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- DLEU7 (Deleted in Lymphocytic Leukemia, 7 (DLEU7))
-
Alternative Name
- DLEU7
-
Background
- Rabbit Anti-DLEU7 Polyclonal Antibody,Leukemia-associated protein 7, Deleted in lymphocytic leukemia 7,DLEU7, located adjacent to the consensus deleted region, and overlapping the 3' end of DLEU1 tail to tail. Human DLEU7 encodes a putative 221 amino acid protein, with significant conservation in rodents. Deletion of chromosome 13q14 is the most frequent genetic aberration in B-cell chronic lymphocytic leukemia (CLL), found in more than 50 % of cases, indicating that this region contains a gene(s) involved in the development of CLL.,DLEU7
-
Gene ID
- 220107
-
UniProt
- Q6UYE1
Target
-